Overview
Status
Active
Registry date
2020-10-22
Share capital
1 000 000,00 PLN
Registered address
ul. Dawidowska 10, 05-500 Zamienie, Poland
Electronic delivery address
AE:PL-38068-69569-UVBTB-15
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 103.77kMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 17.75kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 56.94kMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 64.43kMedianUSD 539.29kAverageUSD 10.66m
Industry
Bank accounts
Registered as a VAT taxpayer on 2013-02-28. Active
87 1240 5989 1111 0010 4306 4833
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 27, 2020 | Transformation registered |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Piotr Bieliński — President of the Management Board
Manner of representation
Each member of the management board independently is entitled to make declarations of will and signatures on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 14,000 | $189,086.98 | 70% | |
Piotr Bieliński (59) | 6,000 | $81,037.28 | 30% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Piotr Bieliński (59) | Shareholder of a limited liability company, 300000.0 PLN | |
Piotr Bieliński (59) | Członek zarządu osoby prawnej której przysługuje powyżej 25 % udziałów | |
Sławomir Harazin (57) | Członek zarządu osoby prawnej która posiada więcej niż 25 % udziałów |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biochem PolskaS.A. | $13,180,007.81 | biochempolska.pl | ||
| PolypharmS.A. | $13,084,716.73 | polypharm.pl | ||
| Surgical Solutionssp. z o.o. | $947,852.75 | surgical-solutions.pl | ||
| MD International Medicalsp. z o.o. | $331,292.14 | md-international.eu | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Screenmedsp. z o.o. | $147,401.05 | screenmed.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Jacek Frey i Wojciech FreyS.K.A. | — | frey.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-06-03 | Name change (Krakvet Marketing → Diagvera) | |
| 2022-11-03 | Share capital change (500,000.00 PLN → 1,000,000.00 PLN) | |
| 2022-07-22 | Name change (Sferis Marketing → Krakvet Marketing) | |
| 2022-07-22 | PKD change (Removed: 58.29.Z, 62.01.Z; Added: 46.90.Z, 47.76.Z) | |
| 2020-10-22 | Entered in the register |
FAQ
The main business activity of Diagvera focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on October 22, 2020.
The headquarters is located at: ul. Dawidowska 10, 05-500 Zamienie.
The management board consists of: Piotr Bieliński (President of the Management Board).
The share capital of the company is PLN 1,000,000 (approx. $270,124).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $103,771, representing an increase of 1.8% compared to 2024.
Yes, in 2025 the company achieved a net profit of $17,745.
The largest operating cost category falls under employee remuneration. This category amounted to $50,162 in 2025, representing 88% of all operating expenses.
Last updated: 2026-06-03
